Business
enVVeno Medical Adds Sandy Prietto to its Executive Team as Vice President of Marketing
MedTech Marketing Leader with Significant New Product Launch Experience for Cardiovascular DevicesKey Addition to Commercial Team as Company Begins Planning
About this update from Envveno Medical Corporation
[{"type":"text","content":"MedTech Marketing Leader with Significant New Product Launch Experience for Cardiovascular DevicesKey Addition to Commercial Team as Company Begins Planning for the VenoValve MonetizationSeveral Upcoming Company Milestones Planned for Q4 of 2024 Including:Completion of PMA Submission Seeking FDA Approval for the VenoValveRelease of One Year Data from VenoValve U.S. Pivotal StudyBeginning of GLP Pre-clinical Study for enVVe in Preparation for enVVe Pivotal Trial IRVINE, CA / ACCESSWIRE / September 3, 2024 / enVVeno Medical Corporation (Nasdaq:NVNO) (\"enVVeno\" or the \"Company\"), a company setting new standards of care for the treatment of venous disease, today announced that Sandy Prietto has joined the Company as Vice President of Marketing. Ms. Prietto brings many years of medical device marketing experience including successful new product launches at Endologix and Edwards Lifesciences.\"In addition to the wealth of marketing experience and success with innovative new product launches that is directly relevant to the commercial launch of the VenoValve, Sandy brings an infectious enthusiasm that will permeate throughout the commercial team and elsewhere across our Company,\" said Robert Berman, enVVeno Medical's Chief Executive Officer. \"We will continue to add talented people like Sandy to our executive team who can help us achieve our goal of building enVVeno Medical into the world's preeminent company for replacement venous valves and the treatment of venous disease.\"\"Throughout my career, I have developed a passion for driving Medtech innovations that have the potential to transform patients' lives. The opportunity to lead the marketing team at enVVeno represents the culmination of all my past work experiences,\" added Ms. Prietto. \"First-in-class medical devices like the VenoValve and enVVe that have the potential to change the treatment paradigm for a pervasive disease like severe Chronic Venous Insufficiency do not occur very often and I am excited to help bring relief to the millions of patients that suffer from this disease.\"Most recently, Ms. Prietto served as head of worldwide marketing at Endologix, where she oversaw the launch of the DETOURä System, a percutaneous transmural arterial bypass therapy which was designated as a breakthrough device by the U.S. Food and Drug Administration (FDA). Prior to that, M...